Results 11 to 20 of about 66 (43)

Evaluation of Newborn Screening for Diseases Using C5-OH as a Marker: Systematic Review of the Literature and Evaluation of 17 Years of C5-OH Screening in the Netherlands. [PDF]

J Inherit Metab Dis
ABSTRACT In 2007, the Dutch newborn screening (NBS) program was expanded to include C5‐OH as a marker to screen for three inborn errors of metabolism (IEMs): 3‐methylcrotonyl‐CoA carboxylase deficiency (3‐MCCD), 3‐hydroxy‐3‐methylglutaryl‐CoA lyase deficiency (HMGCLD) and holocarboxylase synthetase deficiency (HLCSD).
Aukes R, Albersen M, Boelen A, Kluijtmans LAJ, Visser WF, de Vries MC, Bosch AM, C5‐OH NBS Working Group.   +7 more
europepmc   +2 more sources

UEG Week 2025 Moderated Posters [PDF]

United European Gastroenterol J
United European Gastroenterology Journal, Volume 13, Issue S8, Page S189-S802, October 2025.
europepmc   +2 more sources

UEG Week 2025 Poster Presentations [PDF]

United European Gastroenterol J
United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
europepmc   +2 more sources

Comparison of characteristics of patients with lung cancer in U.K. primary care databases: Clinical Practice Research Datalink Aurum and GOLD

Pharmacoepidemiology and Drug Safety, Volume 32, Issue 10, Page 1161-1177, October 2023., 2023
Abstract Introduction In recent years, the number of general practices contributing to the Clinical Practice Research Datalink (CPRD) database GOLD is decreasing. Therefore, for research questions addressing for instance novel treatments requiring up‐to‐date data, sample size will become an important consideration in study feasibility. In recent years,
J. L. Gulikers, A. J. van Veelen, J. H. M. Driessen, P. C. Souverein, V. C. G. Tjan‐Heijnen, L. E. L. Hendriks, R. M. J. M. van Geel, S. Croes   +7 more
wiley   +1 more source

Let’s Talk LMCC (S01E04): Legal, Ethical and Organizational Aspects of Medicine - Confidentiality and Legal Systems

McGill Journal of Medicine, 2023
Welcome to the McGill Journal of Medicine (MJM) Let’s Talk LMCC Review. This podcast series was created to aid medical students studying for the Canadian Medical Council (MCC)’s licensing exam.
Sarah Grech, Lara Khoury, Carolyn Ells, Esther SH Kang, Katherine Lan, Susan Joanne Wang   +5 more
doaj   +1 more source

Development and validation of an HPLC–MS/MS method to simultaneously quantify brigatinib, lorlatinib, pralsetinib and selpercatinib in human K2‐EDTA plasma

Biomedical Chromatography, Volume 37, Issue 6, June 2023., 2023
Abstract A liquid chromatography–tandem mass spectrometry method was developed and validated to quantify the small‐molecule inhibitors (SMIs) brigatinib, lorlatinib, pralsetinib and selpercatinib, which are used in patients with oncogenic‐driven non‐small cell lung cancer.
Judith L. Gulikers, Ard J. van Veelen, Elishia M. J. Sinkiewicz, Yvo M. de Beer, Mariëlle Slikkerveer, Leo M. L. Stolk, Vivianne C. G. Tjan‐Heijnen, Lizza E. L. Hendriks, Sander Croes, Robin M. J. M. van Geel   +9 more
wiley   +1 more source

UEG Week 2023 Moderated Posters

, 2023
United European Gastroenterology Journal, Volume 11, Issue S8, Page 201-534, October 2023.
wiley   +1 more source

UEG Week 2023 Poster Presentations

, 2023
United European Gastroenterology Journal, Volume 11, Issue S8, Page 535-1498, October 2023.
wiley   +1 more source

Exploring the impact of patient‐specific clinical features on osimertinib effectiveness in a real‐world cohort of patients with EGFR mutated non‐small cell lung cancer

International Journal of Cancer, Volume 154, Issue 2, Page 332-342, 15 January 2024.
What's new? Patients with non‐small cell lung cancer (NSCLC) and a sensitizing epidermal growth factor receptor mutation (EGFRm+) potentially benefit from treatment with the third‐generation tyrosine kinase inhibitor osimertinib. Here, the authors evaluated the impact of NSCLC patient characteristics on outcomes associated with osimertinib.
Ard van Veelen, G. D. Marijn Veerman, Marjon V. Verschueren, Judith L. Gulikers, Christi M. J. Steendam, Anita J. W. M. Brouns, Safiye Dursun, Marthe S. Paats, Vivianne C. G. Tjan‐Heijnen, Cor van der Leest, Anne‐Marie C. Dingemans, Ron H. J. Mathijssen, Ewoudt M. W. van de Garde, Patrick Souverein, Johanna H. M. Driessen, Lizza E. L. Hendriks, Robin M. J. M. van Geel, Sander Croes   +17 more
wiley   +1 more source

MJM MedTalks (S02E11): Global Surgery in our “Backyard”; A Discussion with Dr. Evan Wong

McGill Journal of Medicine
McGill Journal of Medicine (MJM) Podcast Series, MJM MedTalks, interviews members of the medical and health sciences community from McGill, and beyond to gain insights into their careers, research, advocacy, and more.
Vanessa Ross, Evan Wong, Katherine Lan, Renée-Claude Bider, Masha Samuel, Samy Amghar, Noha Benharira, Esther SH Kang, Jan Pack, Khiran Arumugam, Susan Joanne Wang   +10 more
doaj